后腹腔镜联合膀胱电切镜行肾盂输尿管癌根治术的手术配合

Surgery cooperation of retroperitoneoscopy together with cystoscope in pelvic ureteral carcinoma radical mastectomy

目的探讨后腹腔镜联合膀胱电切镜行肾盂输尿管癌根治术的护理疗效。方法选取2011年1月～2012年7月采用后腹腔镜联合膀胱电切镜行肾盂输尿管癌根治术的患者37例为观察组,给予相应的手术配合。选取2011年1月前采用传统开放手术行肾盂输尿管癌根治术的患者39例为对照组。比较两组患者的临床指标、临床疗效、并发症情况。结果观察组手术时间明显长于对照组,观察组术中出血量、术后肠功能恢复时间、术后下床活动时间、术后住院时间均明显小于对照组,观察组住院费用明显高于对照组,观察组并发症发生率(0)明显低于对照组(10.3%),差异均有统计学意义(均P<0.05)。结论后腹腔镜联合膀胱电切镜行肾盂输尿管癌根治术配合有效的护理干预可以明显改善患者的预后,创伤小且术后恢复快,并发症少,值得临床推广使用。

Objective To investigate the nursing effect of retroperitoneoscopy together with cystoscope in pelvic ureter- al carcinoma radical masteetomy. Methods 37 patients who were operated by pelvic ureteral carcinoma radical mas- tectomy using retroperitoneoscopy together with cystoscope from January 2011 to July 2012 were selected to be the ob- servation group, and they were given corresponding surgery cooperation. 39 patients operated by pelvic ureteral carci- noma radical mastectomy using traditional open surgery before January 2011 were selected to he the control group. The clinical index, clinical effect and complications of the two groups were compared. Results The operation time of obser- vation group patients obviously longer than that of the control group. The intraoperatve blood soss, postoperative recov- ery time of intestinal peristalsis, activity time out-bed and length of stay of the observation group were significantly less than that of the control group. The hospitalization expense of the observation group was obviously higher than that of the control group. The complications rate of the observation group （0） was significantly lower than that of the control group （10.3%）. All the differences were statistically significant （P 〈 0.05）. Conclusion The method of retroperito- neoscopy together with cystoseope in pelvic ureteral carcinoma radical mastectomy combined with an effective nursing intervention can significantly improve the prognosis of patients, with small trauma, rapid recovery and fewer complica- tions. So it is worth for clinical use.